Sienna Gestion’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
3,541
-15,145
-81% -$4.98M 0.07% 121
2025
Q4
$6.49M Buy
18,686
+1,976
+12% +$668K 0.39% 91
2025
Q3
$4.92M Hold
16,710
0.34% 100
2025
Q2
$5.93M Buy
16,710
+1,506
+10% +$606K 0.41% 86
2025
Q1
$6.43M Sell
15,204
-1,615
-10% -$648K 0.52% 73
2024
Q4
$6.2M Hold
16,819
0.42% 87
2024
Q3
$8.72M Buy
16,819
+3,825
+29% +$2.04M 0.58% 63
2024
Q2
$7.04M Buy
12,994
+81
+0.6% +$42.8K 0.63% 59
2024
Q1
$6.7M Buy
+12,913
New +$6.42M 0.58% 69

Other funds holding ELV

Sienna Gestion's ELV Position: Q1 2026 in Review

Sienna Gestion reduced its Elevance Health (ELV) stake by 81% in Q1 2026, selling an estimated $4.98M and leaving 3,541 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #121.

Sienna Gestion first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.72M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sienna Gestion held 3,541 shares of Elevance Health worth $1.02M as of Q1 2026.
  • Sienna Gestion sold 15,145 Elevance Health shares in Q1 2026, an estimated $4.98M.
  • Elevance Health made up 0.07% of Sienna Gestion's portfolio in Q1 2026, its #121 holding.
  • Sienna Gestion first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • Sienna Gestion's Elevance Health position peaked at $8.72M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sienna Gestion's 13F filing for Q1 2026, filed 15 May 2026.